STAT

‘It’s about love’: Battling a brain tumor, a man finds resilience through storytelling

In telling his story, Michael Bischoff is a case study for an unusual medical question: Can the act of storytelling improve a person’s health?

It was mid-October in St. Joseph, Mo., and Michael Bischoff, 46 and rail thin with dark wispy hair and a faintly visible scar behind his right ear, stood before nursing home residents and their family members, to tell a story of generations.

The community room smelled like hamburgers and potatoes. At Bischoff’s side sat his father, Donald, 75, head down and silent as usual, in a wheelchair, a decades-old scar arcing his scalp.

Their brain tumors had struck 70 years apart. Donald’s was successfully treated when he was a toddler, but he developed a brain condition that ultimately left him depressed and physically debilitated; his wife and three children

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Wegovy And Ozempic Sales, Rising Pharma Layoffs, And More
Sales of the blockbuster Wegovy obesity treatment more than doubled in the first quarter as Novo Nordisk races to make more of the drug to meet surging demand.
STAT2 min readAmerican Government
STAT+: Pharmalittle: We’re Reading About FTC Reviewing Novo-Catalent Deal, Amneal Opioid Settlement, And More
The FTC wants more information on a $16.5 million deal in which Novo Nordisk's parent company would purchase Catalent, a contract drug manufacturer.

Related Books & Audiobooks